Nutromics: Raises US$14M in Funding

Nutromics Raises US$14M in Funding

  • Nutromics, a Brunswick, Australia-based MedTech startup, raised US$14M in funding
  • The round was led by Dexcom Ventures, VU Venture Partners, and Artesian Investments
  • This latest round of funding will support an expansion of clinical studies, expansion of R&D team and investment across both Australian and United States hubs
  • The company is a developing a wearable diagnostic platform that uses DNA technology to enable tracking for multiple targets in the human body using a single patch
  • The company will complete world-first in-human clinical studies of its first DNA sensors in 2022, as well as its integrated alpha prototype device
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Cosegic Strengthens Financial Crime Expertise with Fintrail Acquisition

The acquisition enhances Cosegic's capabilities in combating financial crime.Highlights: Cosegic acquires Fintrail to enhance financial crime capabilities.The acquisition...

Keye Launches AI Co-Pilot for Private Equity Due Diligence

A game-changing tool to enhance efficiency in investment evaluations.Highlights: Keye introduces an AI-powered co-pilot for due diligence.Streamlines the...

Regulators Urged to Prioritize Gen AI Threats Over Quantum Computing Risks

Insights on the evolving regulatory landscape in fintech and AI.Highlights: Exchange Association emphasizes urgency on Gen AI regulatory...

Cryptocurrency Scam Losses Surge to $17 Billion in 2025, Fuelled by AI

Analysis reveals AI-driven schemes are escalating crypto fraud incidences.Highlights: Losses from cryptocurrency scams reached $17 billion in 2025.AI...